The substance abuse treatment market is anticipated to grow at a CAGR of around 10.5% during the forecast period. Substance abuse is referred to as a set of conditions that are associated with the consumption of various mind- and behavior-altering substances. These substances impart a negative impact on the behavioral and health outcomes of the patient. Substance abuse significantly contributes to various economic, social, physical, mental, and public health problems hence, the need for the adoption of treatment is high.
Get Free Sample link @ https://www.omrglobal.com/request-sample/substance-abuse-treatment-market
Increasing acceptance and consumption of alcohol, nicotine, and drugs among the young population in emerging economies and the need to control the addiction is a key factor for the growth of the global substance abuse treatment market. Moreover, increasing disposable income is also driving the market. First, due to increased disposable income, people are more exposed to alcohol and drugs. Moreover, due to the same reason, significant capital expenditure is witnessed in the therapy session and medications.
A full report of Global Substance Abuse Treatment Market available @ https://www.omrglobal.com/industry-reports/substance-abuse-treatment-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Substance Abuse Treatment Market by Treatment Type
- Drug Abuse Treatment
- Methadone
- Buprenorphine
- Naltrexone
- Other
- Nicotine Addiction Treatment
- NRT Therapy
- Varenicline
- Bupropion
- Other
- Alcohol Addiction Treatment
- Acamprosate
- Disulfiram
- Naltrexone
- Benzodiazepines
- Other
Global Substance Abuse Treatment Market by Distribution Channel
- Retail
- Rehabilitation Center
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Adial Pharmaceuticals Inc.
- Alkermes PLC
- Allergan plc (Subsidiary of AbbVie)
- Amphastar Pharmaceuticals, Inc.
- BioCorRx, Inc.
- Bristol Myers Squibb Co.
- Indivior PLC
- Mallinckrodt PLC
- Novartis AG (Sandoz)
- Opiant Pharmaceuticals Inc.
- Pfizer Inc.
- Purdue Pharma L.P.
- Reckitt Benckiser Group plc
- Sun Pharmaceutical Industries Ltd.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Substance abuse treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/substance-abuse-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
